Martin Van Trieste, SVP of Quality at AMGEN, Ann Daly, SAFC Director of Sales and Tom Beil, SAFC VP of Quality and Regulatory Affairs take a moment to smile for the cameras at the build site in New Orleans, LA.
This entry was posted on Wednesday, February 29th, 2012 at 10:25 pm and is filed under .
You can follow any responses to this entry through the RSS 2.0 feed.
You can leave a response, or trackback from your own site.
17 Apr 2014
Thomas Reuters Projects Next Blockbusters
Thomas Reuters analysts just projected the next round of drugs that they feel should be watched a the new blockbusters on the block in the coming year. The list has some sure things and perhaps some s...
16 Apr 2014
US Drug Spending Rises Slightly in 2013
According to latest IMS report, drug spending rose slightly by 1% last year after taking a dip in 2012. This was largely attributed in a drop in lost sales from patent expiries from $29 B in 2012 to &...
16 Apr 2014
Court Clears Way to Biosimilar Herceptin in EU
The High Court in London revoked two patents of Roche's mAb, Herceptin, potentially clearing a path for the introduction of a biosimilar version in the EU. Hospira (and its partner Celltrion) are expe...
14 Apr 2014
Next Takeover Rumor
Supposedly both Novartis and Shire may be leading candidates to buy Belgium-based eye company ThromboGenics. Morgan Stanley is said to be leading the way in discussions towards this end. Also rumored ...